Correlates of fatigue among South African adolescents living with HIV and receiving antiretroviral therapy by Coetzee, Bronwyne et al.
        
Citation for published version:
Coetzee, B, Loades, M, du Toit, S & Kagee, A 2019, 'Correlates of fatigue among South African adolescents
living with HIV and receiving antiretroviral therapy', AIDS and Behavior, vol. 23, no. 3, pp. 602-608.
https://doi.org/10.1007/s10461-018-02384-6
DOI:
10.1007/s10461-018-02384-6
Publication date:
2019
Document Version
Peer reviewed version
Link to publication
This is a post-peer-review, pre-copyedit version of an article published in Aids and Behavior. The final
authenticated version is available online at: https://doi.org/10.1007/s10461-018-02384-6
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 23. Jan. 2020
        
Citation for published version:
Coetzee, B, Loades, M, du Toit, S & Kagee, A 2018, 'Correlates of fatigue among South African adolescents
living with HIV and receiving antiretroviral therapy' AIDS and Behavior.
Publication date:
2018
Document Version
Peer reviewed version
Link to publication
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. Feb. 2019
Title: Correlates of fatigue among South African adolescents living with HIV 
and receiving antiretroviral therapy 
 
Authors:  
1. Bronwynè J. Coetzee¹ 
2. Maria E. Loades² 
3. Stefani Du Toit¹ 
4. Ashraf Kagee¹ 
 
Affiliations 
¹Department of Psychology, Stellenbosch University, South Africa 
²Department of Psychology, University of Bath, England  
 
Details of corresponding author 
Dr. Bronwynè J. Coetzee 
Department of Psychology 
Stellenbosch University 
Private Bag X1 
Matieland 
7602 
South Africa 
Email: bronwyne@sun.ac.za  
021-8083979 
 
 
Acknowledgement  
Many thanks to the clinical staff and healthcare providers for their openness to this 
research and their role in the recruitment of participants. We also thank our 
participants for their willingness to contribute to this study.  
 
Dr Loades is funded by the National Institute for Health Research (Doctoral 
Research Fellowship, DRF-2016-09-021). This report is independent research. The 
views expressed in this publication are those of the authors(s) and not necessarily 
those of the NHS, The National Institute for Health Research or the Department of 
Health.  
 
Funding 
We would like to acknowledge Stellenbosch Universities Sub-Committee A, as well 
as the University of Bath’s Faculty of Humanities and Social Sciences & Department 
of Psychology for funding this research. 
 
Compliance with Ethical Standards 
Conflicts of interest: The authors declare that they have no conflict of interest. 
Ethical Approval: Ethics approval was received from Stellenbosch University Health 
Research Ethics Committee (#HREC N16/03/032) and the Western Cape 
Department of Health. All procedures performed in studies involving human 
participants were in accordance with the ethical standards of the institutional and/or 
national research committee and with the 1964 Helsinki declaration and its later 
amendments or comparable ethical standards. 
Informed consent:  Informed consent was obtained from all individual participants 
included in the study. 
  
Abstract 
Background: Fatigue among adolescents living with HIV is poorly understood. In 
this study, we examined the relationships between fatigue and demographic and 
psychosocial variables to further the understanding of the symptom experience and 
associated factors.  
Method: We recruited consecutive attenders at ART clinics in the Western Cape, 
South Africa (N = 134, age 11-18 years). Participants completed a battery of 
questionnaires, including measures of fatigue, insomnia and mood disturbance.  
Results: Just under a quarter (24.6%) of adolescents reported elevated levels of 
fatigue that affected their functioning. The linear combination of age, depression, and 
insomnia explained 40.6% of the variance in fatigue.  
Conclusion: Amongst adolescents with HIV, fatigue seems a problematic symptom 
associated with poor sleep and mood disturbance. Timely identification and 
management of these potentially disabling symptoms are needed to attain better 
health outcomes and retention in care in this group. Interventions aimed at 
ameliorating these symptoms are needed. 
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Introduction  
Globally and in South Africa, adolescents continue to be at substantial risk of 
HIV infection. The most recent estimates suggest that more than 2 million 
adolescents (10-19 years old) were living with HIV globally, of which 250 000 were 
newly infected (1). With the introduction of antiretroviral therapy (ART), morbidity and 
mortality rates, as well as rates of disease progression have substantially decreased 
(2,3). As such, HIV has now for many years been considered a treatable condition, 
rather than a terminal diagnosis. While ART is able to reduce HIV replication in the 
blood and limit disease progression (4), the treatment does not relieve (and may 
even exacerbate) the numerous disabling symptoms associated with living with a 
chronic illness like HIV. Amongst these disabling symptoms is fatigue. Between 33% 
and 88% of adults living with HIV experience elevated fatigue (5,6), which is 
reportedly present through all stages of disease progression (7) and if left untreated, 
may become more pronounced overtime (6). Similar rates of fatigue are reported 
amongst adolescents in South Africa (about 24.6% using the Chalder Fatigue 
Questionnaire (CFQ)) (8).   
Fatigue is known as extreme tiredness resulting from mental or physical 
exertion or illness, leading to a decrease in the capacity to perform physical and/or 
mental activities (9). When fatigue persists for at least a month, is not relieved by 
rest and impacts on functioning, it is considered to be ‘chronic fatigue’ (9,10). In a 
previous paper we showed that adolescents living with HIV experience fatigue as 
problematic, and perceive it to have a considerable impact on their daily lives, 
including their ability to concentrate at school, and socialise with peers (11). 
In adults living with HIV, various correlates of fatigue have been examined, 
including biological markers such as CD4 count and viral load, sociodemographic 
factors such as age, gender, and income and psychosocial factors such as 
depression, anxiety and insomnia (see Table I). Despite a fairly substantial literature 
on correlates and predictors of fatigue in adults, less is known about the correlates of 
fatigue among adolescents living with HIV. 
 
<Insert table I about here>  
 
The symptom management model (9,12) is an evidence based theoretical 
model that has been applied to the symptom of fatigue among HIV in adults, and 
may be a useful way to conceptualise fatigue in adolescents with HIV (13). It 
postulates that an individual’s experience of their symptoms (e.g. fatigue), the things 
they do to manage these symptoms (e.g. adhere to an ART regimen), and the 
potential outcomes of symptoms (change in severity, frequency or duration) are 
inter-related. Individual variables (e.g. demographic factors, psychological factors, 
and developmental stage), the environment (e.g. social and cultural factors) and 
illness and health related factors (e.g. health status or type of disease) also influence 
symptom management. Understanding more about chronic fatigue in adolescents 
living with HIV, and identifying factors associated with it in this population would 
enable the timely identification and treatment of it, leading to potential remediation. 
Chronic fatigue is potentially a prominent and disabling symptom among 
adolescents living with HIV. Fatigue is one of the most disabling symptoms amongst 
adults living with HIV, and a failure to ameliorate these symptoms has been shown to 
impact on quality of life (14,15) and decrease functional ability(14,16). Children and 
adolescents living with HIV face unique challenges throughout their life course. 
Indeed, adolescents have a lifelong journey with HIV and ART, and quite possibly 
with concomitant fatigue. However, the limited empirical investigation of fatigue in 
this population means that it continues to be poorly understood and relatively 
neglected. Based on evidence in adults with HIV, we hypothesised that age, female 
gender, anxiety, insomnia and depression, would be associated with fatigue. This 
study explored the correlates and predictors of fatigue among HIV-infected 
adolescents in the Western Cape of South Africa. 
 
Methods 
Participants  
Participants were 134 adolescents living with HIV, aged 11 – 18 years. Males 
(N = 56) and females (N = 78) were included. Participants were recruited from 
community clinics or infectious diseases clinics where they were enrolled in an ART 
programme. To be eligible to participate in the study, participants had to be 
sufficiently competent in either Afrikaans or English. Clinic staff at both sites referred 
participants to our study. Adolescents were not referred for participation (and 
subsequently excluded) by clinic staff if they presented on the day with significant 
developmental delay, were in need of emergency medical assistance, or had a 
severe psychiatric illness (e.g. florid psychotic symptoms).  
 
Procedure 
Consecutive clinic attenders who were potentially eligible to participate were 
briefly informed about the study by clinic staff during their follow-up appointments at 
an ART clinic or hospital site. If they were willing to consider taking part, the clinic 
staff referred them to a research assistant (SdT). The research assistant met with 
them in a private room and explained the study to them in greater depth. 
Participation was voluntary and participants could withdraw from the study at any 
time without consequences for their treatment. Those who agreed to participate were 
asked to complete a consent form. After providing written consent, participants 
completed a battery of questionnaires that were available in either Afrikaans or 
English. If a participant was unable to understand the questionnaire items, they were 
helped by the research assistant. Participants were given a mobile phone top-up 
voucher and refreshments as a token of appreciation for their participation in the 
study.  
 
Measures 
 
Demographic questionnaire: Participants completed a demographic questionnaire 
that captured information on gender, age, ethnicity, social class (lower -, working - or 
middle class) and employment status.  
 
Fatigue: The 11-item Chalder Fatigue Scale (CFQ) (17) assesses the severity of 
physical and mental fatigue over the last month. Each item is rated on a 4-point 
scale, ranging from 0 (less than usual) to 3 (much more than usual). Scores were 
summed, with a maximum total score of 33. A total score of ≥18 is an indication of 
problematic levels of fatigue in adults (18), and has been widely applied in studies of 
fatigue in adolescents (19). The CFQ had high internal consistency in our sample, 
with an alpha coefficient of 0.83.   
 
Insomnia: The 8-item Athens Insomnia Scale (AIS) assesses sleep disturbances 
over the past month. It includes problems with sleep induction, awakening during the 
night, sleep duration, sleep quality, well-being, mental and physical functioning, and 
daytime sleepiness. In Chinese adolescents, a score of ≥7 was found to be optimal 
for establishing sleep disturbance (20). The AIS had a high internal consistency in 
this sample, with an alpha coefficient of 0.82. 
 
Depression: The 10-item depression subscale of the Revised Children’s Anxiety and 
Depression Scale (RCADS) is validated for children and young people aged 7-18 
years (21). The items assess various symptoms of depression, including: feeling sad 
or empty, anhedonia, trouble sleeping, change in appetite, lack of energy, 
disturbance in cognition, feelings of worthlessness, lack of desire to participate in 
activities, and restlessness. The depression subscale of the RCADS has high validity 
and reliability in both the clinical and nonclinical population (21,22). For the purposes 
of the current study, one item was excluded from analysis as this item measures 
fatigue. In order to account for the excluded item, all raw scores were divided by 9 
and multiplied by 10. Raw scores from the RCADS were then converted into T-
scores, which are age- and gender-adjusted scores. A T-score of ≥65 indicates 
possible clinical depression (23). In the current study, the RCADS depression 
subscale had a high internal consistency, with an alpha coefficient of 0.86. 
 
Anxiety: The 6-item generalised anxiety subscale of the RCADS asks about the 
tendency to worry about things, worrying about bad things happening to oneself or 
family members, and thinking about death. Raw scores for this RCADS subscale 
were converted to T-scores (as described above). A T-score of ≥65 indicates 
possible clinical anxiety (23). The general anxiety subscale of the RCADS has been 
shown to have a high validity and reliability in clinical and nonclinical populations 
(21,22). The RCADS (anxiety subscale) had a high internal consistency, with an 
alpha coefficient of 0.89. 
 
The measures were not available in Afrikaans. At the outset of the study, the 
research assistant, an Afrikaans speaking master’s student, translated these 
questionnaires from English to Afrikaans, and the accuracy of the translation was 
checked by a senior member of the research team (BC).  
 
Ethical considerations: We obtained ethical approval for this study from the 
Stellenbosch University Research Ethics Committee (#HREC N16/03/032) and the 
Western Cape Department of Health. Participants were asked to complete an 
informed consent form and were assured of confidentiality of their data. All 
participants gave written informed consent. Since most of the participants attended 
the consultation without a parent/caregiver, we received ethics clearance for a 
parental waiver of consent.  
 
Data analysis: The data were analysed using the Statistical Package for Social 
Sciences (SPSS), version 24. The data were checked for normality and outliers, and 
positively skewed variables (depression and insomnia) were corrected with log 
transformations. We calculated Cronbach’s alpha for each measure to determine 
internal consistency, which are reported where each measure has been described in 
the methods. We used descriptive statistics (frequencies, percentages, means, and 
standard deviations) to summarise the data pertaining to demographic and symptom 
characteristics. Further, we used an independent sample t-test to compare male and 
female participants’ scores on fatigue, insomnia, depression, and anxiety. We 
calculated bivariate correlations amongst age, gender, fatigue, insomnia, depression, 
and anxiety. Variables that significantly correlated with fatigue were then entered into 
a hierarchical regression model, with fatigue as the outcome variable. Predictors 
were added to the regression model in blocks, where block 1 contained demographic 
variables (age, gender), and block 2 and 3 contained psychosocial variables, i.e. 
depression and insomnia, respectively.   
 
 
Results  
 
Demographic characteristics of the sample  
 
A total of 134 adolescents (78 female; 56 male) participated in the study. The mean 
age was 14.3 (SD = 1.9) years and participants identified as either coloured (N = 24; 
17.9%) or Black (N = 110; 82.1%). All participants, except for one, were attending 
school. In terms of social class, participants identified as either lower- (N = 94; 
70.1%), working- (N = 38; 28.4%), or middle-class (N = 2; 1.5%). There were no 
significant differences (p>.05) between male and female participants on these 
variables.  
 
Symptom characteristics of study participants 
Applying thresholds from the existing literature, each of the measures identified a 
proportion of participants who reported clinically significant symptoms; 24.6% (n=33) 
fatigue, 20.1% (n = 27) insomnia, 9.7% (n = 13) depression and 6.7% (n = 9) anxiety 
(see Table II). Further, female participants scored significantly higher (p = <.05) on 
insomnia, and symptoms of depression compared to male participants.  
 
<Insert table II about here> 
 
Bivariate correlations  
As can be seen in Table III, age, depression and insomnia all correlated significantly 
with fatigue. These variables were moderately and positively correlated with one 
another.   
 
<Insert table III about here> 
 
Regression diagnostics 
The various regression diagnostics, including the Cook's and Mahalanobis 
distances, and variance inflation factors were within the acceptable range for 
regression analysis.  
 
Predicators of fatigue 
Table IV presents the regression model summary with fatigue as the 
criterion/outcome variable. The linear combination of the predictors, namely age, 
gender, depression and insomnia explained 40.6 % of the variance in fatigue. Table 
V shows that age, depression and insomnia were each unique and significant 
predictors of fatigue.  
 
<Insert table IV about here> 
 <Insert table V about here> 
Discussion 
To our knowledge, this is the first study to report on the correlates and 
predictors of fatigue amongst HIV-infected adolescents. Our previous qualitative 
work with 14 HIV-infected adolescents with fatigue showed the disruptive impact of 
fatigue on concentration at school and illustrated how fatigue can be a barrier to 
interacting with peers (11). The current study has further highlighted the presence of 
fatigue among a subsample of adolescents living with HIV, and has indicated how 
the symptom experience of fatigue may be linked to other symptoms, including 
mental health.  
We found that around a quarter (24.6%) of adolescents were experiencing 
clinically significant fatigue, with one in five experiencing insomnia and one in ten 
reporting possible depression. Notably, fewer adolescents reported symptoms of 
depression and insomnia compared to fatigue. The difference in the rates between 
depression, insomnia and fatigue is important to note, given the considerable overlap 
between symptoms of fatigue, depression and insomnia (6). Despite this overlap, 
studies show that fatigue presents independently of depression, and insomnia (9) as 
was the case in our study (6,14,24). Indeed, participants in our study were more 
likely to report fatigue than depression, indicating that depression alone cannot 
account for all fatigue experienced by those living with HIV, which is consistent with 
other existing findings in adults (5). This finding also demonstrates that targeted 
interventions aimed at addressing fatigue as a primary outcome are necessary and 
important.  
Our findings showed that older adolescents, those with higher levels of 
depressive symptoms, and those with more problems with sleep, were more likely to 
also be fatigued. These findings are echoed in the adult literature (6,7,15). Notably, 
insomnia was moderately positively correlated with fatigue. In their study, Low et al 
(2013) demonstrated that even when controlling for depression, insomnia remained 
a significant predictor of fatigue among adults with HIV, and that this relationship 
persisted when controlling for biological markers such as CD4 count. Research is 
needed to explore the relationship between biological markers (such as CD4 count 
and viral load) and fatigue in adolescents living with HIV.  
We showed that, in linear combination, all of the variables, except gender, 
explained a substantial amount of the variance in fatigue. In the literature there are 
mixed results as to whether gender is predictive of fatigue. While some studies in 
adults with HIV have shown female gender to be associated with fatigue (9), others 
have found no association between the two (25). These differences may be 
attributable to methodology, and in studies where other potential confounding 
variables have been controlled for, the apparent association between gender and 
fatigue disappears.     
The literature demonstrates that failure to ameliorate symptoms of fatigue 
among adults living with HIV affects adherence to ART (26–28) and the same may 
be true for adolescents, given the rates of fatigue found in the current study. Further, 
the literature demonstrates that fatigue in adults with HIV does not remit 
spontaneously over time and if left untreated, symptoms of fatigue may worsen (6). 
Again, this may be true of adolescents. As mentioned, we identified clinically 
significant symptoms of depression in around one in ten adolescents with HIV in our 
sample. This finding is comparable to prevalence rates of depression found in other 
samples of adolescents in South Africa (29,30). However, as depression symptoms 
also contribute to non-adherence to ART in adults with HIV (31), mood is another 
important factor to bear in mind, consistent with the symptom management model 
that highlights the inter-relations between different factors in symptom perpetuation 
and management. Early-detection of fatigue (and indeed depression) amongst 
adolescents with HIV may be achievable within schools settings. For example, our 
previous qualitative work with HIV-infected adolescents who reported fatigue, 
reported poor concentration and social withdrawal (11). As such, it may be 
worthwhile exploring the feasibility of equipping school staff with the necessary skills 
to identify these symptoms and make appropriate referrals,  
In addition to highlighting areas for future research, these findings highlight 
the importance of identifying and treating fatigue as soon as it is reported or 
observed amongst adolescents. A measurement tool such as the Chalder Fatigue 
Questionnaire (CFQ) is easy to administer, cost-effective, and has shown reliability 
amongst HIV-infected adolescents (8). The CFQ may be a useful tool to incorporate 
in clinical settings as part of routine care and symptom management in order to 
identify adolescents with symptoms of fatigue.  
While our study has explored the symptom experience of fatigue in this 
population, it has some limitations. Firstly, we recruited consecutive clinic attenders 
at two healthcare facilities in the Western Cape, which limits generalizability to other 
settings. Secondly, our study was cross-sectional, which limits any causal inference 
from our findings. Future studies would benefit from longitudinal designs to better 
understand the severity of fatigue among adolescents living with HIV over time and 
in particular, throughout adolescence and into adulthood. Thirdly, we did not collect 
data on income, or average household income, which is known to influence fatigue in 
the adult HIV literature. For example, studies have shown that low income and 
unemployment are associated with higher levels of fatigue (5,15). Finally, we relied 
on self-report measures and did not include physiological data such as viral load, 
which would be important to collect in future studies.  
 
Conclusion  
Fatigue appears to be a symptom that is experienced among a considerable minority 
of adolescents living with HIV and is associated with sleep disturbance and with 
depression. Adolescents who experience elevated levels of fatigue may also be 
struggling with their mood and with maintaining their sleep, which may impact on 
their adherence to ART. However, as these factors did not fully account for fatigue, it 
is also important that future research explore other factors/biological markers which 
may contribute to fatigue, such as viral load. Given the disabling nature of fatigue 
amongst adolescents with HIV, there is a need to develop appropriate interventions 
to ameliorate these symptoms, and prevent these symptoms from escalating and 
interfering with adherence to ART, school completion, and retention in health care. 
This study has furthered the understanding of the fatigue experience in this 
population, which has implications for symptom identification and management.   
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Table I. Table summarising evidence of factors associated with fatigue in adults living with 
HIV 
 
Factor 
Type 
Factor Evidence pertaining to an association with fatigue 
Biological 
marker 
CD4 count Lower CD4 count associated with higher levels of fatigue 
(1–3). However, no evidence of an association was 
found in other studies (4–6).   
 Viral load Higher viral loads associated with increased fatigue (7). 
However, no evidence of an association was found in 
other studies (6,8,9).  
Sociodemo
graphic 
Age Fatigued persons with HIV have been shown to be 
younger than non-fatigued persons with HIV(10).  
 Gender Women are more likely to have higher levels of fatigue 
(6).  
 Income/employme
nt status 
Inadequate income and unemployment are associated 
with higher levels of fatigue (11).  
Psychosoc
ial 
Depression  Higher levels of depressive symptoms/depression are 
associated with higher levels of fatigue (4–6,8).  
 Anxiety Fatigue is associated with state and trait anxiety (8). 
Increases in anxiety, stress and depression have been 
shown to increase fatigue (12).  
 Insomnia Those participants who reported higher levels of sleep 
problems also reported higher levels of fatigue (13).  
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Table II: Symptom characteristics of study participants by gender 
   Male (N = 56) Female (N = 78)   
Variable Cut-offs % scoring 
above cut-
off 
Mean SD Mean SD t p 
Fatigue ≥18 on CFQ 24.6 14.12 3.89 15.42 3.71 -1.93 0.06 
Insomnia ≥7 on AIS 20.1 3.07 2.98 4.54 3.54 -2.53 0.01* 
Depression ≥65 on 
RCADS 
9.7 42.02ᵃ 9.24 46.63ᵃ 13.89 -2.16 0.03* 
Anxiety ≥65 on 
RCADS 
6.7 41.84ᵃ 10.92 45.38ᵃ 13.84 -1.59 0.11 
*p ≤ 0.05         
ᵃ Adjusted T-
scores were 
used for 
analysis  
        
 
  
Table III. Bivariate correlation matrix of variables 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
  
  Age Fatigue Depression Insomnia Anxiety 
Age 1     
Fatigue .325** 1    
Depression .174* .502** 1   
Insomnia .272** .538** .444** 1  
Anxiety .239** .158 .514** .232** 1 
Table IV. Model summary with fatigue scores (Likert scores) as dependant variable 
 
    
Model   R  R Square Adjusted R Square Std. Error of the 
estimate 
1  .375a  .141  .127   3.57246 
2  .566b  .321  .305   3.18826 
3  .637c  .406  .387   2.99313 
a Predictors: Gender, Age     
b Predictors: Gender, Age, Depression     
           c Predictors: Gender, Age, Depression, Insomnia   
  
Table V. Predictors of fatigue (CFQ) 
 
Model Unstandardized 
Coefficients 
Standardiz
ed 
Coefficient
s 
t Sig. 
B Std. Error Beta 
1 (Constant) 3.319 2.522  1.316 .190 
Age .647 .156 .337 4.152 .000 
Gender 1.451 .627 .188 2.314 .022 
2 (Constant) -18.636 4.364  -4.270 .000 
Age .491 .142 .255 3.463 .001 
Gender .824 .570 .107 1.446 .151 
Depression 15.399 2.623 .439 5.872 .000 
3 (Constant) -10.922 4.472  -2.442 .016 
Age .348 .137 .181 2.539 .012 
Gender .365 .545 .047 .669 .505 
Depression 10.904 2.675 .311 4.076 .000 
Insomnia_ 4.104 .954 .341 4.301 .000 
 
 
